Hologic Valuation
| HOLX Stock | USD 74.56 0.07 0.09% |
At this time, the firm appears to be fairly valued. Hologic retains a regular Real Value of $74.46 per share. The prevalent price of the firm is $74.56. Our model calculates the value of Hologic from evaluating the firm fundamentals such as Current Valuation of 17.04 B, return on equity of 0.11, and Return On Asset of 0.073 as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Hologic's price fluctuation is very steady at this time. Calculation of the real value of Hologic is based on 3 months time horizon. Increasing Hologic's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Hologic is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Hologic Stock. However, Hologic's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 74.56 | Real 74.46 | Hype 74.47 | Naive 73.1 |
The intrinsic value of Hologic's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Hologic's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Hologic helps investors to forecast how Hologic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hologic more accurately as focusing exclusively on Hologic's fundamentals will not take into account other important factors: Hologic Total Value Analysis
Hologic is currently expected to have valuation of 17.04 B with market capitalization of 16.63 B, debt of 2.63 B, and cash on hands of 2.39 B. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Hologic fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
17.04 B | 16.63 B | 2.63 B | 2.39 B |
Hologic Investor Information
About 99.0% of the company shares are owned by institutional investors. The book value of Hologic was currently reported as 22.68. The company has Price/Earnings To Growth (PEG) ratio of 1.65. Hologic had not issued any dividends in recent years. The entity had 2:1 split on the 3rd of April 2008. Based on the measurements of operating efficiency obtained from Hologic's historical financial statements, Hologic is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Hologic Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Hologic has an asset utilization ratio of 45.49 percent. This suggests that the Company is making $0.45 for each dollar of assets. An increasing asset utilization means that Hologic is more efficient with each dollar of assets it utilizes for everyday operations.Hologic Ownership Allocation
Hologic has a total of 223.07 Million outstanding shares. The majority of Hologic outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Hologic to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Hologic. Please pay attention to any change in the institutional holdings of Hologic as this could imply that something significant has changed or is about to change at the company. Also note that almost six hundred fourty-six thousand eight hundred ninety invesors are currently shorting Hologic expressing very little confidence in its future performance.Hologic Profitability Analysis
The company reported the previous year's revenue of 4.1 B. Net Income was 565.7 M with profit before overhead, payroll, taxes, and interest of 2.49 B.About Hologic Valuation
Our relative valuation model uses a comparative analysis of Hologic. We calculate exposure to Hologic's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Hologic's related companies.Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for womens health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts. Hologic operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 6705 people.
Hologic Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 227.6 M | |
| Quarterly Earnings Growth Y O Y | 0.111 | |
| Forward Price Earnings | 16.2866 |
Additional Tools for Hologic Stock Analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.